| scholarly article | Q13442814 |
| P50 | author | Marc A. Judson | Q38803534 |
| Haroon Chaudhry | Q86779681 | ||
| P2093 | author name string | Kevin Lee | |
| Recai Yucel | |||
| Amanda Louis | |||
| P2860 | cites work | Current and emerging pharmacological treatments for sarcoidosis: a review | Q24633717 |
| The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital | Q33589366 | ||
| Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. | Q33596658 | ||
| ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders | Q33772723 | ||
| British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment | Q33775858 | ||
| Established and experimental medical therapy of pulmonary sarcoidosis | Q34327118 | ||
| Presenting characteristics as predictors of duration of treatment in sarcoidosis | Q34566301 | ||
| The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States | Q34649024 | ||
| Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics | Q36552573 | ||
| Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. | Q37057108 | ||
| Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. | Q37649330 | ||
| Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. | Q39723920 | ||
| Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis | Q45726271 | ||
| Health-related quality of life of persons with sarcoidosis | Q48009430 | ||
| The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. | Q51674401 | ||
| Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. | Q53642494 | ||
| Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. | Q64912779 | ||
| An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment | Q77339548 | ||
| The diagnosis of sarcoidosis | Q81420991 | ||
| P433 | issue | 4 | |
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 526-531 | |
| P577 | publication date | 2015-02-07 | |
| P1433 | published in | Respiratory Medicine | Q2659932 |
| P1476 | title | The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis | |
| P478 | volume | 109 |
| Q89595622 | Association of Medication Adherence and Clinical Outcomes in Sarcoidosis |
| Q38766783 | Clinical management of pulmonary sarcoidosis |
| Q89552202 | Comprehensive Care for Patients with Sarcoidosis |
| Q92670173 | Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns |
| Q46218709 | Disease Burden and Variability in Sarcoidosis. |
| Q55094212 | Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis. |
| Q64270443 | First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative |
| Q38923440 | Managing fatigue in sarcoidosis - A systematic review of the evidence. |
| Q89689250 | Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia |
| Q95565170 | Sarcoidosis |
| Q64270412 | Sarcoidosis in the UK: insights from British Thoracic Society registry data |
| Q92916641 | Sarcoidosis: An Ill-afforded Disease |
| Q64236182 | The Burden of Sarcoidosis Symptoms from a Patient Perspective |
| Q35914526 | The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal |
| Q52583860 | The Impact of Autoimmune Hepatitis and its Treatment on Health Utility. |
Search more.